| ¿µ¹® | aging, senescence | ÇÑ±Û | ³ëÈ, ´ÄÀ½ |
|---|---|---|---|
| ¼³¸í | ³ªÀÌ ¸Ô´Â´Ù´Â Àǹ̷Π»ç¿ëµÇ±âµµ ÇÏÁö¸¸ ÀϹÝÀûÀ¸·Î´Â ¼ºÀåÀÌ ¿Ï·á, Á¤ÁöµÇ°í ±× ÀÌÈÄ¿¡ ÀϾ´Â ¸ðµç °úÁ¤À» °¡¸®Å²´Ù. ³ªÀ̸¦ ¸Ô¾î°¨¿¡ µû¶ó »ýüÀÇ ¿©·¯ °¡Áö ±â´ÉÀÌ ÀúÇϵǴµ¥, ÀϹÝÀûÀ¸·Î ¼¼Æ÷¿¡ »ö¼Ò°¡ ÃàÀûµÇ°Å³ª ¼¼Æ÷ÀÚü³ª ÇÙÀÌ ÀÛ¾ÆÁö´Â Çö»óÀÌ´Ù. °³°³ÀÇ ¼¼Æ÷ ±â´Éµµ ÀúÇϵǰí, ¼¼Æ÷ ³»¿¡ »ö¼Ò°¡ Ä§ÂøµÇ¸ç, ±â°üÀº ¾Ï°¥»öÀ» ¶í´Ù. ¶ÇÇÑ ÇǺδ ¾ã¾ÆÁö°í ÅÐÁָӴϵµ À§ÃàµÇ¸ç, ¸ð¹ßÀº »ö¼Ò¸¦ ÀÒ°í Å»¸ðµÈ´Ù. ÇöÀç ¸¹Àº ÇÐÀÚµéÀº ¼¼Æ÷³» DNA°¡ ²÷¾îÁö°Å³ª ²÷¾îÁø °æ¿ì ¼öº¹·ÂÀÌ °¨¼ÒÇϰųª, ¸é¿ª·ÂÀÌ ÀúÇÏÇϱ⠶§¹®À¸·Î º¸°í ÀÖ´Ù. ³ëȰ¡ ÀϾ´Â °ÍÀº ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó¼ Å©°Ô ´Ù¸¥µ¥ ½Å°æ¼¼Æ÷ó·³ Å¾¼ Á×À» ¶§±îÁö ¼¼Æ÷ºÐ¿ÇÏÁö ¾Ê´Â ¼¼Æ÷´Â ³ëȰ¡ µÎµå·¯Áö°í °íȯÀ̳ª °ñ¼öÀÇ ¼¼Æ÷ó·³ Ç×»ó ºÐ¿ÇÏ´Â ¼¼Æ÷´Â ³ëÈÇö»óÀÌ °ÅÀÇ ÀϾÁö ¾Ê´Â´Ù. ¹ßº´°ú Á×À½ÀÇ È®·üÀÌ ³ô¾ÆÁöÁö¸¸, ³ë¼è¼º º¯È¿Í º´Àû º¯È¿ÍÀÇ °æÁ¦´Â ¸íÈ®ÇÏÁö ¾Ê´Ù. ³ë¼è¸¦ ¾ß±âÇÏ´Â ³ëÈÀÇ º»ÁúÀû ¿øÀο¡ ´ëÇØ¼´Â ¾ÆÁ÷ Á¤¼³ÀÌ ¾ø´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | health | ÇÑ±Û | °Ç° |
|---|---|---|---|
| ¼³¸í | ½ÅüÀû-Á¤½ÅÀûÀ¸·Î º´ÀÌ ¾ø´Â »óÅÂ. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ÇåÀå¿¡´Â ¡°°Ç°À̶õ Áúº´ÀÌ ¾ø°Å³ª Çã¾àÇÏÁö ¾ÊÀº °Í¸¸ ¸»ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó ½ÅüÀû-Á¤½ÅÀû-»çȸÀûÀ¸·Î ¿ÏÀüÈ÷ ¾È³çÇÑ »óÅ¿¡ ³õ¿© ÀÖ´Â °Í¡±À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. »ç¶÷Àº ÀÎÁ¾-Á¾±³-Á¤Ä¡-°æÁ¦-»çȸÀÇ »óÅ ¿©Çϸ¦ ºÒ¹®ÇÏ°í °íµµÀÇ °Ç°À» ´©¸± ±Ç¸®°¡ ÀÖ´Ù´Â °ÍÀ» ¸í½ÃÇÑ °ÍÀÌ´Ù. Áï °ú°Å¿¡´Â, °Ç°À̶õ À°Ã¼Àû-Á¤½ÅÀûÀ¸·Î Áúº´À̳ª ÀÌ»óÀÌ ¾ø°í, °³ÀÎÀûÀ¸·Î Á¤»óÀûÀÎ »ýȰÀ» ¿µÀ§ÇÒ ¼ö ÀÖ´Â ½Åü»óŸ¦ ¸»ÇÏ¿´À¸³ª, ¿À´Ã³¯¿¡´Â °³ÀÎÀÌ »çȸ»ýȰ¿¡ ÀÇÁ¸ÇÏ´Â °æÇâÀÌ Ä¿Áü¿¡ µû¶ó¼ »çȸ°¡ °¢ °³ÀÎÀÇ °Ç°¿¡ ±â´ëÇÏ´Â °Íµµ ¸¹¾ÆÁ³±â ¶§¹®¿¡ »çȸÀûÀÎ °Ç°À̶õ ¸é¿¡¼ ÀÌ¿Í °°Àº Á¤Àǰ¡ »ý°Ü³ °ÍÀ¸·Î º¸ÀδÙ. Çѱ¹ÀÇ Çå¹ý¿¡´Â °Ç°À» ¡°¸ðµç ±¹¹ÎÀÌ ¸¶¶¥È÷ ´©·Á¾ß ÇÒ ±âº»ÀûÀÎ ±Ç¸®¡±¶ó°í ±ÔÁ¤Çϰí ÀÖ¾î °Ç°À» ÇϳªÀÇ ±âº»±ÇÀû °³³äÀ¸·Î º¸°í ÀÖ´Ù. ¶ÇÇÑ Áúº´ÀÌ ¾ø´Â »óŶó´Â ¼öµ¿Àû °Ç°¿¡ ´ëÇÑ Åµµ¿¡¼, ±ÝÁÖ-±Ý¿¬ µî »ýȰ½À°üÀÇ º¯È³ª ¿îµ¿ °°Àº Àû±ØÀûÀ¸·Î °Ç°ÇØÁö·Á´Â ³ë·Â µî ´Éµ¿Àû ŵµ°¡ °Á¶µÇ°í ÀÖ´Ù. °Ç°ÀÇ ±¸Ã¼Àû ¿ä¼Ò·Î´Â À°Ã¼ÀûÀÎ ÇüÅÂÀû ¿ä¼Ò(½ÅÀå-üÁß°ú °°Àº ¿ÜÇüÀû °èÃø°ªÀ̳ª ³»ÀåÀÇ ¿©·¯ ±â°ü µî)¿Í ±â´ÉÀû ¿ä¼Ò(¿©·¯ ±â°üÀÇ »ý¸®±â´ÉÀ̳ª Á¾ÇÕÀûÀΠü·Â µî), Á¤½Å±â´ÉÀû ¿ä¼Ò·Î ºÐ·ùÇÏ¿© Æò°¡Çϱ⵵ ÇÑ´Ù. |
||
| ¿µ¹® | public health | ÇÑ±Û | °øÁߺ¸°Ç |
|---|---|---|---|
| ¼³¸í | Áý´ÜÀ̳ª Áö¿ª»çȸÀÇ °Ç°À» ¿¬±¸ÇÏ´Â ¿¹¹æÀÇÇÐ. 18¼¼±â Áß¿±ºÎÅÍ »ê¾÷Çõ¸í¿¡ ÀÇÇØ Àα¸°¡ µµ½Ã·Î ÁýÁßµÇ°í »ýȰȯ°æÀÌ ¿¾ÇȵǾî ÄÝ·¹¶ó³ª °áÇÙ µîÀÌ À¯ÇàÇ߱⠶§¹®¿¡ ±× ´ëÃ¥À¸·Î ź»ýÇÏ°Ô µÇ¾ú´Ù. ¿ì¸® ³ª¶ó¿¡¼´Â ±¤º¹ ÈĺÎÅÍ º¸°Ç¼ÒÀÇ ¼³Ä¡³ª ´ëÇÐÀÇ °Á ½Å¼³ µî ±Ù´ëÀûÀÎ °øµ¿º¸°ÇÇàÁ¤ÀÌ ÀÌ·ç¾îÁö°Ô µÇ¾ú´Ù. ÀÌ ¶§±îÁö´Â ÀÏÁ¦ ½Ä¹Î´ç±¹ÀÇ °æÂû·Â¿¡ ÀÇÇÑ ¸í·É°ú ´Ü¼ÓÀ¸·Î ½ÃÁ¾ ÇØ¿Ô´Ù. ÇöÀçµµ ¿ì¸®³ª¶óÀÇ µµ½Ã ȯ°æ Á¤ºñ°¡ À¯·´ ¿©·¯ ³ª¶ó³ª ¹Ì±¹¿¡ ºñÇØ µÚÁø °ÍÀº ÀÌ·¯ÇÑ ¿µÇâ ¶§¹®ÀÌ´Ù. ÃÖ±Ù¿¡´Â °øÁߺ¸°ÇÀÇ ÁÖµÈ ¸ñÀûÀÌ Àü¿°º´ ´ëÃ¥¿¡¼ ¾Ï-³úÁßdz-½ÉÀ庴-´ç´¢º´ µî »ýȰ½À°üº´ ´ëÃ¥À¸·Î ¿Å°ÜÁö°í ÀÖ´Ù. |
||
| ¿µ¹® | industrial health | ÇÑ±Û | »ê¾÷º¸°Ç |
|---|---|---|---|
| ¼³¸í | ±â¾÷ü´Â ±Ù·ÎÀÚÀÇ »ý¸í°ú °Ç°¿¡ ´ëÇÑ ¾ÈÀüÀ§»ý°ü¸®Ã¼Á¦°¡ ±â¾÷ÀÇ Á¾·ù¿Í ±Ô¸ð¿¡ »óÀÀÇÏ°Ô Àǹ«ÈÇÒ Çʿ䰡 ÀÖ´Ù. »ê¾÷º¸°ÇÀ̶õ ÀÌ·¯ÇÑ ³ëµ¿À§»ý¹®Á¦ÀÇ °³³äÀ» ´õ¿í Æø³Ð°Ô È®´ëÇÏ°í Æ¯È÷ ±Ù·ÎÀÚÀÇ °Ç°À» ÃËÁø½Ã۰í ÀçÇØ¸¦ ¿¹¹æÇѴٰųª ÄèÀûÇÑ ±Ù·Îȯ°æÀ» Á¶¼ºÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ´Ù. |
||
| MHP | hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1... |
|---|---|
| AJKD | American Journal of Kidney Diseases |
| JOC | Journal of Oncologic Clinical(?) |
| AEM | Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph... |
| AM | Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ... |
| CSHA | Canadian Study of Health and Aging |
|---|---|
| JAMA | Journal of the American Medical Association |
| NEJM | New England Journal of Medicine |
| BLSA | Baltimore Longitudinal Study of Aging |
| LSOA | Longitudinal Study of Aging |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| aging | The gradual changes in the structure and function of humans and animals that occur with the passage of time, that do not result from disease or other gross accidents, and that eventually lead to the increased probability of death as the person or animal grows older. It does not apply to microorganisms. (12 Dec 1998) |
| aging, premature | Changes in the organism associated with senescence, occurring at an accelerated rate. (12 Dec 1998) |
| cell aging | The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of apoptosis. (12 Dec 1998) |
| clonal aging | The deterioration in successive generations of a clone; thus paramecia and other simple forms, if allowed to reproduce asexually for a number of generations, invariably undergo deterioration, the characters of each group of descendants progressively departing from those of the original sexually produced ancestor. (05 Mar 2000) |
| skin aging | The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. (12 Dec 1998) |
| erythrocyte aging | Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days. (12 Dec 1998) |
| civilian health and medical program of the uniformed services | See: CHAMPUS. (12 Dec 1998) |
| health and human services | See HHS. (12 Dec 1998) |
| health care economics and organizations | The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector. (12 Dec 1998) |
| health care facilities, manpower, and services | The services provided in the delivery of health care, associated facilities in health care, and attendant manpower required or available. (12 Dec 1998) |
| health care quality, access, and evaluation | The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery. (12 Dec 1998) |
| health services needs and demand | Health services required by a population or community as well as the health services that the population or community is able and willing to pay for. It includes the identification and assessment of the needs as measured by objective criteria and standards. (12 Dec 1998) |
| national institute for occupational safety and health | An institute of the centres for disease control and prevention which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals. (12 Dec 1998) |
| state health planning and development agencies | Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|